Key result
Reduced stress-echo coronary flow velocity reserve strongly predicts MACE and all-cause mortality across heart diseases.
Why the study?
Despite technical and conceptual advances, coronary flow velocity reserve evaluation by stress echocardiography remains underutilized globally in routine clinical practice.
Evaluating coronary flow velocity reserve via stress echocardiography provides robust prognostic value for predicting MACE and mortality across multiple cardiovascular conditions, supporting its broader integration into clinical workflows.
CFVR via stress echocardiography may enhance risk stratification across CVDs; leaves open whether routine integration improves outcomes.
Although evaluating coronary flow velocity reserve (CFVR) via stress echocardiography (SE) has been available for over three decades, its integration into routine clinical practice remains underutilized globally despite substantial technical and conceptual advances. A diminished CFVR serves as a potent predictor of major adverse cardiovascular events (MACE) and all-cause mortality across a broad spectrum of cardiovascular diseases. Its prognostic value is particularly robust in epicardial coronary artery disease, heart failure, coronary microvascular dysfunction, nonischemic cardiomyopathies, metabolic disorders (e.g., diabetes mellitus and obesity), hypertrophic cardiomyopathy, systemic autoimmune diseases, and cardiac allograft vasculopathy. This comprehensive narrative review details the technical methodology for interrogating resting and stress-induced coronary flow velocity (CFV) under physical and pharmacological protocols. Furthermore, it highlights the clinical applicability of CFVR by synthesizing single-center observational insights with evidence from large-scale multicenter registries, advocating for its broader adoption into diagnostic workflows to refine risk stratification and guide therapeutic management.
No takes yet. Share an insight, caveat, or question.
Jorge Alfredo Lowenstein (2026) conducted a review in Cardiovascular diseases. Coronary flow velocity reserve (CFVR) via stress echocardiography was evaluated. Diminished coronary flow velocity reserve evaluated via stress echocardiography serves as a potent predictor of major adverse cardiovascular events and all-cause mortality across multiple heart diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: